Document is current
Any future updates will be listed below
-
Authors
Fiscalini, Allison https://orcid.org/0000-0002-9639-4053
Blum, Kelly
Fergus, Kirkpatrick
Hiatt, Robert A.
Naeim, Arash
Kaster, Andrea
Scheuner, Maren T.
van ‘t Veer, Laura J.
LaCroix, Andrea Z.
Borowsky, Alexander D.
Olopade, Olufunmilayo I.
Park, Hannah L.
Esserman, James
Lancaster, Rachael
Heditsian, Diane
Brain, Susie
Lee, Vivian
Goodman, Deborah L.
Ross, Katherine S.
Wenger, Neil
Parker, Barbara A.
Madlensky, Lisa
Tice, Jeffrey A.
Shieh, Yiwey
Ziv, Elad
Arasu, Vignesh A.
Anton-Culver, Hoda
Kaplan, Celia P.
Rhoads, Kim F.
Badal, Kimberly
Hogarth, Michael
Petruse, Antonia
Soto, Irene A.
Leggat-Barr, Katherine
Goodman, Steffanie
Atamer, Jennifer
Ryu, Rita
Adduci, Kelly
Matthews, Jeffrey B.
Eklund, Martin
,
Sabacan, Leah P.
Esserman, Laura https://orcid.org/0000-0001-9202-4568
-
Funding
Funding for this research was provided by:
Patient Centered Outcomes Institute (PCS-1402-10749)
National Cancer Institute (R01CA237533)
Breast Cancer Research Foundation (SPEC-18-006, SPEC-22-018, SPEC-24-026)
Robert Wood Johnson Foundation (Pioneer Pitch Award 71864)
Safeway Foundation
Bright Pink
Mount Zion Health Fund
V Foundation
Sanford Foundation
Salesforce
- License Information
-
More Information
Article History
Received: 20 September 2025
Accepted: 6 April 2026
First Online: 24 May 2026
Competing interests
: Olufunmilayo Olopade is co-founder of CancerIQ, owns stock in TempusAI, and was provided research support from the Color Foundation for genetic testing in Nigeria. Laura van ‘T Veer is a part-time employee and stockholder of Agendia NV. Laura J. Esserman is a Medical Advisory Panel member for Blue Cross Blue Shield and has received consulting fees from UpToDate. Lisa Madlensky is on the clinical advisory council for VieCure. Michael Hogarth is a medical informatics advisor for Medeloop.ai, Lifelink, and Virta Health. The remaining authors declare no competing interests.
